journal article May 31, 2014

Neurologic indications for therapeutic plasma exchange: 2013 update

Journal of Clinical Apheresis Vol. 29 No. 4 pp. 211-219 · Wiley
View at Publisher Save 10.1002/jca.21331
Abstract
Neurologists commonly use therapeutic plasma exchange (TPE) to treat a number of conditions. This concise review considers the most common neurologic indications for TPE. It focuses on Guillain–Barré syndrome and myasthenia gravis and also the role of TPE in chronic inflammatory demyelinating polyneuropathy, Lambert–Eaton syndrome, multiple sclerosis, neuromyelitis optica, paraproteinemic polyneuropathy, Sydenham's chorea, and natalizumab‐associated progressive multifocal leukoencephalopathy. As with any treatment, the proven efficacy, cost, side effects, and availability must be considered before initiation of therapy. J. Clin. Apheresis 29:211–219, 2014. © 2014 Wiley Periodicals, Inc.
Topics

No keywords indexed for this article. Browse by subject →

References
128
[3]
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis

Zbigniew M. Szczepiorkowski, Nicholas Bandarenko, Haewon C. Kim et al.

Journal of Clinical Apheresis 10.1002/jca.20129
[16]
Raphaël JC "Plasma exchange for Guillain‐Barré syndrome" Cochrane Database Syst Rev (Online) (2012)
[24]
Haymaker WE "The Landry‐Guillain‐Barré syndrome; a clinicopathologic report of 50 fatal cases and a critique of the literature" Medicine (1949)
[27]
Gracey DR "Respiratory failure in Guillain‐Barré syndrome: a 6‐year experience" Mayo Clin Proc (1982)
[37]
Practice parameter: Immunotherapy for Guillain–Barré syndrome

R.A.C. Hughes, E.F.M. Wijdicks, R. Barohn et al.

Neurology 10.1212/wnl.61.6.736

Showing 50 of 128 references

Cited By
38
Neurological Research
Metrics
38
Citations
128
References
Details
Published
May 31, 2014
Vol/Issue
29(4)
Pages
211-219
License
View
Cite This Article
Kelly Gwathmey, Rasheed A. Balogun, Ted Burns (2014). Neurologic indications for therapeutic plasma exchange: 2013 update. Journal of Clinical Apheresis, 29(4), 211-219. https://doi.org/10.1002/jca.21331